Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Herpes Zoster 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Papillomavirus Infections 2Neoplasms 2Melanoma 2Lung Neoplasms 2Influenza, Human 2Glioblastoma 2Whooping Cough 1Waldenstrom Macroglobulinemia 1Tetanus 1Spondylitis, Ankylosing 1Psoriasis 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Glandular and Epithelial 1Multiple Myeloma 1Meningitis 1Medulloblastoma 1Hematologic Neoplasms 1Glioma 1Diphtheria 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1

Interventions

Certolizumab Pegol 3MEDI2070 2Infliximab 2secukinumab 1golimumab 1Vaccines 1Saline Solution 1Papillomavirus Vaccines 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Herpes Zoster Vaccine 1Calcium Dobesilate 1Calcitriol 1Bupivacaine 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Crohn Disease × Vaccines × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡